Mainboard IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jun 05 to Jun 09 2026
Price Band
₹42 - 45
Current GMP
₹48.25 (+7.22%)
Subscription
53.68 times
IPO Details
| IPO Date | 5 to 9 Jun, 2026 |
| Listing Date | Fri, Jun 12, 2026 |
| Face Value | ₹ 1 per share |
| Price Band | ₹42 to ₹45 |
| Issue Price | ₹45 per share |
| Lot Size | 333 Shares |
| Sale Type | OFS only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 3,08,59,704 shares (agg. up to ₹ 139 Cr) |
| Offer for Sale | 3,08,59,704 shares of ₹ 1 (agg. up to ₹ 139 Cr) |
| Share Holding Pre Issue | 12,29,18,109 shares |
| Share Holding Post Issue | 12,29,18,109 shares |
| BSE Script Code / NSE Symbol | 544785 / |
| ISIN | INE0JUI01012 |
IPO Date
5 to 9 Jun, 2026
Listing Date
Fri, Jun 12, 2026
Face Value
₹ 1 per share
Price Band
₹42 to ₹45
Issue Price
₹45 per share
Lot Size
333 Shares
Sale Type
OFS only
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Total Issue Size
3,08,59,704 shares (agg. up to ₹ 139 Cr)
Offer for Sale
3,08,59,704 shares of ₹ 1 (agg. up to ₹ 139 Cr)
Share Holding Pre Issue
12,29,18,109 shares
Share Holding Post Issue
12,29,18,109 shares
BSE Script Code / NSE Symbol
544785 /
ISIN
INE0JUI01012
IPO Subscription Details
| Anchor | 1 |
| QIB (Ex Anchor) | 19.77 |
| NII | 161.49 |
| bNII (> ₹10L) | 183.16 |
| sNII (< ₹10L) | 118.15 |
| Retail | 26.85 |
| Total ** | 53.68 |
Anchor
1
QIB (Ex Anchor)
19.77
NII
161.49
bNII (> ₹10L)
183.16
sNII (< ₹10L)
118.15
Retail
26.85
Total **
53.68
Day Wise Sub
| Day | QIB (Ex Anchor) | NII | NII (> ₹10L) | NII (< ₹10L) | Retail | Total |
|---|---|---|---|---|---|---|
| Jun 5 (Day 1) | 0.00 | 2.03 | 1.32 | 3.45 | 2.43 | 1.65 |
| Jun 8 (Day 2) | 0.17 | 6.70 | 5.04 | 10.03 | 6.22 | 4.60 |
| Jun 9 (Day 3) | 19.77 | 161.49 | 183.16 | 118.15 | 26.85 | 53.68 |
DayJun 5
(Day 1)
QIB (Ex Anchor)0.00
NII2.03
NII (> ₹10L)1.32
NII (< ₹10L)3.45
Retail2.43
Total1.65
DayJun 8
(Day 2)
QIB (Ex Anchor)0.17
NII6.70
NII (> ₹10L)5.04
NII (< ₹10L)10.03
Retail6.22
Total4.60
DayJun 9
(Day 3)
QIB (Ex Anchor)19.77
NII161.49
NII (> ₹10L)183.16
NII (< ₹10L)118.15
Retail26.85
Total53.68
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 12-06-2026 | 45.00 | 2.75(6.11%) | 47.75 |
| 11-06-2026 | 45.00 | 2.75(6.11%) | 47.75 |
| 10-06-2026 | 45.00 | 2.75(6.11%) | 47.75 |
| 09-06-2026 | 45.00 | 3.5(7.78%) | 48.5 |
| 08-06-2026 | 45.00 | 6.5(14.44%) | 51.5 |
| 07-06-2026 | 45.00 | 6.5(14.44%) | 51.5 |
| 06-06-2026 | 45.00 | 6.5(14.44%) | 51.5 |
| 05-06-2026 | 45.00 | 11.75(26.11%) | 56.75 |
| 04-06-2026 | 45.00 | 12(26.67%) | 57 |
| 03-06-2026 | 45.00 | 0(0.00%) | 45 |
| 02-06-2026 | 45.00 | 0(0.00%) | 45 |
| 01-06-2026 | 45.00 | 0(0.00%) | 45 |
| 31-05-2026 | 45.00 | 0(0.00%) | 45 |
| 30-05-2026 | 45.00 | 0(0.00%) | 45 |
| 29-05-2026 | 45.00 | 0(0.00%) | 45 |
| 28-05-2026 | 45.00 | 0(0.00%) | 45 |
| 27-05-2026 | 45.00 | 0(0.00%) | 45 |
| 26-05-2026 | 45.00 | 0(0.00%) | 45 |
Date12-06-2026
Price45.00
GMP2.75(6.11%)
Estimate List Price47.75
Date11-06-2026
Price45.00
GMP2.75(6.11%)
Estimate List Price47.75
Date10-06-2026
Price45.00
GMP2.75(6.11%)
Estimate List Price47.75
Date09-06-2026
Price45.00
GMP3.5(7.78%)
Estimate List Price48.5
Date08-06-2026
Price45.00
GMP6.5(14.44%)
Estimate List Price51.5
Date07-06-2026
Price45.00
GMP6.5(14.44%)
Estimate List Price51.5
Date06-06-2026
Price45.00
GMP6.5(14.44%)
Estimate List Price51.5
Date05-06-2026
Price45.00
GMP11.75(26.11%)
Estimate List Price56.75
Date04-06-2026
Price45.00
GMP12(26.67%)
Estimate List Price57
Date03-06-2026
Price45.00
GMP0(0.00%)
Estimate List Price45
Date02-06-2026
Price45.00
GMP0(0.00%)
Estimate List Price45
Date01-06-2026
Price45.00
GMP0(0.00%)
Estimate List Price45
Date31-05-2026
Price45.00
GMP0(0.00%)
Estimate List Price45
Date30-05-2026
Price45.00
GMP0(0.00%)
Estimate List Price45
Date29-05-2026
Price45.00
GMP0(0.00%)
Estimate List Price45
Date28-05-2026
Price45.00
GMP0(0.00%)
Estimate List Price45
Date27-05-2026
Price45.00
GMP0(0.00%)
Estimate List Price45
Date26-05-2026
Price45.00
GMP0(0.00%)
Estimate List Price45
IPO Important Dates
| IPO Open | Fri, Jun 5, 2026 |
| IPO Close | Tue, Jun 9, 2026 |
| Allotment | Wed, Jun 10, 2026 |
| Refund | Thu, Jun 11, 2026 |
| Credit of Shares | Thu, Jun 11, 2026 |
| Listing | Fri, Jun 12, 2026 |
IPO Open
Fri, Jun 5, 2026
IPO Close
Tue, Jun 9, 2026
Allotment
Wed, Jun 10, 2026
Refund
Thu, Jun 11, 2026
Credit of Shares
Thu, Jun 11, 2026
Listing
Fri, Jun 12, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 333 | ₹14,985 |
| Retail (Max) | 13 | 4,329 | ₹1,94,805 |
| S-HNI (Min) | 14 | 4,662 | ₹2,09,790 |
| S-HNI (Max) | 66 | 21,978 | ₹9,89,010 |
| B-HNI (Min) | 67 | 22,311 | ₹10,03,995 |
ApplicationRetail (Min)
Lots1
Shares333
Amount₹14,985
ApplicationRetail (Max)
Lots13
Shares4,329
Amount₹1,94,805
ApplicationS-HNI (Min)
Lots14
Shares4,662
Amount₹2,09,790
ApplicationS-HNI (Max)
Lots66
Shares21,978
Amount₹9,89,010
ApplicationB-HNI (Min)
Lots67
Shares22,311
Amount₹10,03,995
Financial Information
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 327.60 | 261.36 | 250.54 | 288.90 |
| Total Income | 275.57 | 331.29 | 304.62 | 281.65 |
| Profit After Tax | 27.03 | 24.38 | 12.21 | 5.82 |
| EBITDA | 37.55 | 40.07 | 24.88 | 17.17 |
| NET Worth | 223.05 | 195.60 | 176.29 | 163.84 |
| Reserves and Surplus | 210.92 | 183.89 | 164.51 | 152.30 |
| Total Borrowing | 39.79 | 26.60 | 36.89 | 51.87 |
Period EndedAssets
31 Dec 2025327.60
31 Mar 2025261.36
31 Mar 2024250.54
31 Mar 2023288.90
Period EndedTotal Income
31 Dec 2025275.57
31 Mar 2025331.29
31 Mar 2024304.62
31 Mar 2023281.65
Period EndedProfit After Tax
31 Dec 202527.03
31 Mar 202524.38
31 Mar 202412.21
31 Mar 20235.82
Period EndedEBITDA
31 Dec 202537.55
31 Mar 202540.07
31 Mar 202424.88
31 Mar 202317.17
Period EndedNET Worth
31 Dec 2025223.05
31 Mar 2025195.60
31 Mar 2024176.29
31 Mar 2023163.84
Period EndedReserves and Surplus
31 Dec 2025210.92
31 Mar 2025183.89
31 Mar 2024164.51
31 Mar 2023152.30
Period EndedTotal Borrowing
31 Dec 202539.79
31 Mar 202526.60
31 Mar 202436.89
31 Mar 202351.87
Key Performance Indicator
| ROE | 13.02% |
| ROCE | 14.82% |
| Debt/Equity | 0.18 |
| RoNW | 12.12% |
| PAT Margin | 9.81% |
| EBITDA Margin | 14.03% |
| Price to Book Value | 2.48 |
ROE
13.02%
ROCE
14.82%
Debt/Equity
0.18
RoNW
12.12%
PAT Margin
9.81%
EBITDA Margin
14.03%
Price to Book Value
2.48
IPO Reservation
| QIB Shares Offered | 1,54,29,851 |
| − Anchor Investor Shares Offered | 92,57,696 |
| − QIB (Ex. Anchor) Shares Offered | 61,72,155 |
| NII (HNI) Shares Offered | 46,28,956 |
| − bNII > ₹10L | 30,85,971 |
| − sNII < ₹10L | 15,42,985 |
| Retail Shares Offered | 1,08,00,897 |
| Total Shares Offered | 3,08,59,704 |
QIB Shares Offered
1,54,29,851
− Anchor Investor Shares Offered
92,57,696
− QIB (Ex. Anchor) Shares Offered
61,72,155
NII (HNI) Shares Offered
46,28,956
− bNII > ₹10L
30,85,971
− sNII < ₹10L
15,42,985
Retail Shares Offered
1,08,00,897
Total Shares Offered
3,08,59,704
Information about company
Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods.
The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports.
Its product portfolio is classified into three segments:
Hexagon Nutrition has a PAN-India omnichannel distribution network covering retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, it works with over 358 distributors across India, including 8 with multi-state presence.
The company has established overseas offices in South Africa, Uzbekistan, and Hong Kong to support international operations. Its products have been exported to more than 75 countries across Asia, Africa, Europe, and South America between fiscals 2023 and 2025.
Hexagon Nutrition maintains two dedicated in-house R&D facilities at Nasik and Chennai, supported by a team of 12 qualified professionals. As of March 31, 2026, the company employed 527 people.
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App